Molecularly, uterine Leiomyoma (LM) presents important genetic dysfunctions such as alterations in RAD51, BRCA1, MED12 and HMGA2,21 genes related to DNA repair and cell growth. This evidence concerns the gene BRCA1 and lymphangioma.